NVS - BeiGene gets FDA approval for esophageal cancer drug Tevimbra
2024-03-14 18:46:24 ET
More on BeiGene
- BeiGene Still Bleeding Red Ink Despite Blockbuster Drug
- BeiGene: Debating On Finally Establishing A Position
- BeiGene gains as access to leukemia drug Brukinsa expands
- BeiGene gets FDA accelerated approval for Brukinsa for follicular lymphoma
- Seeking Alpha’s Quant Rating on BeiGene